SEARCH

SEARCH BY CITATION

References

  • Antinori, A.A., Cingolani, A., De Luca, A., Gaidano, G., Ammassari, A., Larocca, L.M., Ortona, L. (1999) Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. Annals of Neurology, 5, 259260.
  • Beck, R., Westdörp, I., Jahn, G., Schäfer, H., Kanz, L., Einsele, H. (1999) Detection of Epstein-Barr virus DNA in plasma from patients with lymphoproliferative disease after allogeneic bone marrow transplantation or peripheral blood stem cell transplantation (letter). Journal of Clinical Microbiology, 37, 34303431.
  • Callan, M.F., Tan, L., Annels, N., Ogg, G.S., Wilson, J.D.K., O'Callaghan, C.A., Steven, N., McMichael, A.J., Rickinson, A.B. (1998) Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. Journal of Experimental Medicine, 9, 13951402.
  • Cornelissen, J.J., Fibbe, W.E., Schattenberg, A.V.M.B., Petersen, E.J., Willemze, R., De Witte, TH.J.M., Löwenberg, B., Verdonck, L.F., Van Den Biezen, A., Brand, R. (1998) A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplantation, 21, S66S70 (Suppl. 3).
  • Curtis, R.E., Travis, L.B., Rowlings, P.A., Socié, G., Kingma, D.W., Banks, P.M., Jaffe, E.M., Sale, G.E., Horowitz, M.M., Witherspoon, R.P., Shriner, D.A., Weisdorf, D.J., Kolb, H.-J., Sullivan, K.M., Sobocinski, K.A., Gale, R.P., Hoover, R.N., Fraumeni, J.F., Deeg, H.J. (1999) Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood, 94, 22082216.
  • Faye, A., Van Den Abeele, T., Peuchmaur, M., Mathieu-Boue, A., Vilmer, E. (1998) Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders. Lancet, 352, 1285.
  • Fischer, A., Blanche, S., Le Bidois, J., Bordigoni, P., Garnier, J.L., Niaudet, P., Morinet, F., Le Deist, F., Fischer, A.-M., Griscelli, C., Hirn, M. (1991) Anti-B-cell monoclonal antibodies in the treatment of severe B–cell lymphoproliferative syndrome following bone marrow and organ transplantation. New England Journal of Medicine, 324, 14511456.
  • Gan, Y.J., Sullivan, J.L., Sixbey, J.W. (1994) Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. Journal of Infectious Diseases, 170, 436439.
  • George, D., Barnett, L., Boulad, F., Childs, B., Castro-Malaspina, H., Jabukowski, A., Kernan, N.A., Papadopoulos, E., Small, T.N., Szabolcs, P., Young, J., Koulova, L., O'Reilly, R.J. (1998) Semi-quantitative PCR analysis of genomic EBV DNA post-BMT allows close surveillance of patients at risk for development of EBV-lymphoproliferative disorders (EBV-LPD) allowing prompt intervention. Blood, 92, 437a(Suppl. 1).
  • Green, M., Cacciarelli, T.V., Mazariegos, G.V., Sigurdsson, L., Qu, L., Rowe, D.T., Reyes, J. (1998) Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation, 66, 16411644.
  • Gross, T.G., Steinbusch, M., DeFor, T., Shapiro, R.S., McGlave, P., Ramsay, N.K.C., Wagner, J.E., Filipovich, A.H. (1999) B cell lymphoproliferative disorders following hematopoetic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplantation, 23, 251258.
  • Gustafsson, A., Levitsky, V., Zou, J.Z., Frisan, T., Dalianis, T., Ljungman, P., Ringden, O., Winiarski, J., Ernberg, I., Masucci, M.G. (2000) Epstein-Barr (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood, 95, 807814.
  • Haque, T., Amlot, P.L., Helling, N., Thomas, J.A., Sweny, P., Rolles, K., Burroughs, A.K., Prentice, H.G., Crawford, D.H. (1998) Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. Journal of Immunology, 160, 62046209.
  • Heslop, H.E., Ng, C.Y.C., Li, C., Smith, C.A., Loftin, S.K., Krance, R.A., Brenner, M.K., Rooney, C.M. (1996) Long term restauration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Medicine, 2, 551555.
  • Kimura, H., Morita, M., Yabuta, Y., Kuzushima, K., Kato, K., Kojima, S., Matsuyama, T., Morishima, T. (1999) Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. Journal of Clinical Microbiology, 37, 132136.
  • Knowles, D.M., Cesarman, E., Chadburn, A., Frizzera, G., Chen, J., Rose, E.A., Michler, R.E. (1995) Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood, 85, 552565.
  • Kuehnle, J., Huls, M.H., Liu, Z., Semmelmann, M., Krance, R.A., Brenner, M.K., Rooney, C.M., Heslop, H.E. (2000) CD20 monoclonal antibody (Rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoetic stem-cell transplantation. Blood, 95, 15021505.
  • Limaye, A.P., Huang, M.L., Atienza, E.E., Ferrenberg, J.M., Corey, L. (1999) Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders. Journal of Clinical Microbiology, 37, 11131116.
  • Löwenberg, B., Wagemaker, G., Van Bekkum, D.W., Sizoo, W., Sintnicolaas, K., Hendriks, W.D.H., Hagenbeek, A. (1986) Graft-versus-host disease following transplantation of one log versus two log T-lymphocyte-depleted bone marrow from HLA-identical donors. Bone Marrow Transplantation, 1, 133140.
  • Lucas, K.G., Small, T.N., Heller, G., Dupont, B., O'Reilly, R.J. (1996) The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood, 87, 25942603.
  • Lucas, K.G., Burton, R.L., Zimmerman, S.E., Wang, J., Cornetta, K.G., Robertson, K.A., Lee, C.H., Emmanuel, D.J. (1998) Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood, 91, 36543661.
  • Micallef, I.N.M., Chhanabhai, M., Gascoyne, R.D., Shephard, J.D., Fung, H.C., Nantel, S.H., Toze, C.L., Klingemann, H.-G., Sutherland, H.J., Hogge, D.E., Nevill, T.J., Le, A., Barnett, M.J. (1998) Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience. Bone Marrow Transplantation, 22, 981987.
  • Milpied, N., Vasseur, B., Parquet, N., Antoine, C., Quartier, P., Carret, A.S., Bouscary, D., Faye, A., Bourbigot, D., Reguerre, Y., Stoppa, A.M., Bourquard, P., Hurault de Ligny, B., Dubief, F., Mathieu-Boue, A., Leblond, V. (2000) Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Annals of Oncology, 11, S113S116(Suppl. 1).
  • Niesters, H.G.M., Van Esser, J., Fries, E., Wolthers, K.C., Cornelissen, J., Osterhaus, A.D.M.E. (2000) Development of a real-time quantitative assay for detection of Epstein-Barr virus. Journal of Clinical Microbiology, 38, 712715.
  • Papadopoulos, E., Ladanyi, M., Emmanuel, D., Mackinnon, S., Boulad, F., Carabasi, M.H., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Small, T.N., Young, J.W., Kernan, N.A., O'Reilly, R.J. (1994) Infusions of donor lymphocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New England Journal of Medicine, 330, 11851191.
  • Rooney, C.M., Smith, C.A., Ng, C.Y.C., Loftin, S., Li, C., Krance, R.A., Brenner, M.K., Heslop, H.E. (1995a) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet, 345, 913.
  • Rooney, C.M., Loftin, S.K., Holladay, M.S., Brenner, M.K., Krance, R.A., Heslop, H.E. (1995b) Early detection of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. British Journal of Haematology, 89, 98103.
  • Savoie, A., Perpête, C., Carpentier, L., Joncas, J., Alfieri, C. (1994) Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood, 83, 27152722.
  • Slaper-Cortenbach, I.C.M., Wijngaarden-Du Bois, M.J.G.J., De Vries-Van Rossen, A., Borst, H.P.E., Van Der Lelie, H., Van Heugten, H.G., Verdonck, L.F., Wulffraat, N.M., Hoogerbrugge, P.M. (1999) The depletion of T-cells from hematopoietic stem cell transplants. Rheumatology, 38, 751754.
  • Small, T.N., Papadoupolos, E.B., Boulad, F., Black, P., Castro-Malaspina, H., Childs, B.H., Collins, N., Gillio, A., George, D., Jabukowski, A., Heller, G., Fazzari, M., Kernan, N., MacKinnon, S., Szabolcs, P., Young, J.W., O'Reilly, R.J. (1999) Comparison of immune reconstitution after unrelated and related T-cell depleted bone marrow transplantation: effect of patient age and donor lymphocyte infusion. Blood, 93, 467480.
  • Verdonck, L.F., Dekker, A.W., De Gast, G.C., Van Kempen, M.L., Lokhorst, H.M., Nieuwenhuis, K. (1994) Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood, 83, 30903096.
  • Yamamoto, M., Kimura, H., Hironaka, T., Hirai, K., Hasegawa, S., Kuzushima, K., Shibata, M., Morishima, T. (1995) Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. Journal of Clinical Microbiology, 33, 17651768.
  • Zingg, W., Bossart, W., Berli, E., Nadal, D. (1999) Detection and quantification of cell-free Epstein-Barr virus by polymerase chain reaction and subsequent DNA enzyme immunoassay. Journal of Virological Methods, 79, 141148.